The Pharmacy Times® Immunization Resource Center is a comprehensive resource for clinical news and expert insights on common immunizations, such as flu, zoster, and COVID-19 vaccines.
November 20th 2024
Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization
1.5 Credits / Infectious Disease
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Disease
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Disease, Pulmonology
View More
Immunizations: Active Versus Passive
May 11th 2019Mary Koslap‐Petraco, DNP, PNPPC‐BC, CPNP, FAANP, Stony Brook University School of Nursing, discusses the difference between active and passive immunizations, and how they work to prevent disease. This video was filmed at the 2019 National Association of Pediatric Nurse Practitioners (NAP NAP) annual meeting in New Orleans.
Watch
Study Shows Precancerous Cervical Lesions Have Declined
April 22nd 2019Precancerous cervical lesions, known as high-grade cervical lesions (CIN2+) can develop a few years after infection and have been used to monitor human papillomavirus (HPV) vaccine impact since cancers can take decades to develop.
Read More
Reassuring Parents Who Are on the Fence About Vaccines
April 3rd 2019Mary Koslap‐Petraco DNP, PNPPC‐BC, CPNP, FAANP of Stony Brook University School of Nursing and Pediatric Nurse Practitioner House Calls advises nurses to listen to concerned parents and assure them they want the best for their children.
Watch
Study: 2 Strains of HPV Decrease Due to HPV Vaccination
March 3rd 2019Investigators from the CDC Human Papillomavirus (HPV) Vaccine Impact Monitoring Project (HPV-IMPACT) sought to determine whether HPV types 16 and 18, which are responsible for approximately 70% of cervical cancers worldwide, are also decreasing.
Read More